Physician

Richard B Rothschild, MD

According to 2025 Medicare claims, Richard Rothschild, MD (NPI: 1700847126) practices cardiology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is CABRILLO CARDIOLOGY MEDICAL GROUP INC. (NPI: 1518930270; TIN: 952741568) and primary practice location at 93030-0191. Rothschild is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Rothschild's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 716 traditional Medicare patients, billed 26,314 HCPCS/CPT codes, and received $1,585,683 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 5,352 prescription claims across 580 beneficiaries totaling $1,098,672 in drug costs, led by Eliquis (Apixaban). DME data shows 36 claims. Open Payments data shows 125 records totaling $8,272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $494,595 to $1,585,683. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $329,338 to $1,098,672. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $18,211 and ending at $2,975.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	835	11,411	$494,595
2016	809	10,843	$441,559
2017	859	12,863	$503,484
2018	868	11,897	$527,434
2019	880	11,487	$676,312
2020	775	5,643	$692,030
2021	764	5,535	$666,561
2022	801	5,932	$725,677
2023	778	11,589	$1,070,331
2024	716	26,314	$1,585,683

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	368	3,885	$329,338
2016	388	4,054	$404,938
2017	424	4,308	$543,907
2018	488	4,463	$579,074
2019	504	4,592	$695,209
2020	521	5,013	$830,206
2021	523	5,000	$972,231
2022	539	4,855	$1,070,115
2023	535	4,813	$1,103,373
2024	580	5,352	$1,098,672

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	76	$4,486
2016	N/R	26	$1,499
2017	N/R	15	$748
2018	N/R	17	$944
2019	N/R	90	$3,640
2020	N/R	75	$2,989
2021	N/R	80	$3,684
2022	N/R	94	$4,370
2023	N/R	58	$2,767
2024	N/R	36	$1,575

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	398	825	$145
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	398	788	$103
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	360	2,744	$52
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	383	3,096	$42
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	437	808	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	203	12,611	$240,115
Xarelto	Rivaroxaban	180	12,849	$234,115
Repatha Sureclick	Evolocumab	153	7,978	$151,814
Entresto	Sacubitril/Valsartan	87	5,490	$102,218
Farxiga	Dapagliflozin Propanediol	55	4,650	$83,701

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,044
E1392	Portable oxygen concentrator, rental	Y	N/R	18	$532

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	123	$6,634	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$1,638	CVRx, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard B. Rothschild, MD?

Tedicare shows public-source Medicare data for Richard B. Rothschild, MD (NPI 1700847126), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard B. Rothschild, MD have ACO affiliation data?

Richard B. Rothschild, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Richard B. Rothschild, MD?

Richard B. Rothschild, MD is linked to CABRILLO CARDIOLOGY MEDICAL GROUP INC. (billing NPI 1518930270) in the available physician profile data.

Does Richard B. Rothschild, MD have Open Payments data?

Richard B. Rothschild, MD has 125 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.